Navigation Links
Tahoma, Colorado Springs and Salt Lake City Have the Highest Percentage of HIV Patients in the U.S. Who Are Left Untreated
Date:9/16/2010

NASHVILLE, Tenn., Sept. 16 /PRNewswire/ -- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, estimates that Tahoma, WA; Colorado Springs, CO and Salt Lake City, UT have the highest percentage of HIV patients who are left untreated. PatientFinder, HealthLeaders-InterStudy's analytics tool, finds that in these areas, 79 percent, 74 percent and 77 percent, respectively, of HIV positive individuals are not receiving any treatment and have prescription drug insurance.

"The high percentage of untreated patients who have prescription drug insurance in these markets is a great opportunity for pharmaceutical companies wishing to grow their patient base," says Andrew Laubscher, product director, PatientFinder. "Their focus should be on small- and mid-size markets to most effectively drive volume growth among patients who are not receiving treatment."

In addition, there are still an additional nine markets in the United States that have treatment rates below 20%, according to PatientFinder. While there are seven major U.S. markets with HIV treatment rates above 90%, there is a high variation in treatment rates across the U.S. that leave a significant amount of HIV patients untreated.

About PatientFinderPatientFinder covers each of the 50 U.S. states and U.S. metropolitan statistical areas (MSAs) and provides:

  • Disease-specific prevalence numbers for each U.S. state and MSA.
  • Examination of treatment rates for the disease population to create percent treated and percent untreated estimates by state and MSA.
  • Unique analysis of the untreated population examined through a filter of pharmacy benefit coverage. The end result is an estimate of how many patients are untreated but can afford therapy within each territory -- the true local measure of opportunity for pharmaceutical companies.

  • Indications covered in 2010 to include*:

  • Alzheimer's disease
  • Asthma
  • Bipolar depression
  • Chronic obstructive pulmonary disease
  • Crohn's disease
  • Dyslipidemia
  • Hepatitis C virus
  • HIV
  • Hypertension
  • Major depression
  • Multiple sclerosis
  • Parkinson's disease
  • Psoriasis
  • Rheumatoid arthritis
  • Schizophrenia
  • Type 2 diabetes (non-insulin)
  • Ulcerative colitis

  • *Indications subject to change.

    Why Pharmaceutical Companies Need This InformationWith the type of information included in PatientFinder, pharmaceutical organizations can identify the local markets that offer the greatest opportunity for their branded drug. Companies can identify markets that are underserved and determine if they should increase direct-to-consumer advertising, work with the local managed care organizations to increase awareness of the disease and benefits of their drug or align sales representatives to maximize market potential.

    About HealthLeaders-InterStudyHealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.

    About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

    All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Erin O'Leary

    Elizabeth MarshallHealthLeaders-InterStudy

    Decision Resources, Inc.781-993-2641

    781-993-2563eoleary@dresources.com

    emarshall@dresources.com
    '/>"/>

    SOURCE HealthLeaders-InterStudy
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. CO-REC Ready to Assist Colorado Health Care Providers in Implementing Electronic Health Record Systems and Achieving Meaningful Use
    2. Forensic Laboratories Selected for Colorado Companies to Watch Award
    3. Colorado-Based Spectranetics Corporation to Pay $5 Million to Resolve Allegations Relating to its Medical Devices
    4. Colorado MRI Clinic Blends Ultra Patient Care with Significant Cost Savings
    5. Denver-Ft. Collins Ophthalmologist First in Colorado to Implant nanoFLEX Lens
    6. American Lung Association in Colorados Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver
    7. Colorado Cancer Research Program Will Host Golf Event to Drive the Message that Clinical Trials Play a Vital Role in the Quest to Find a Cure for Cancer
    8. Frost & Sullivan Recognizes Timoptic(R) (timolol maleate) as Best Brand Name Beta Blocker for Glaucoma: Timoptic Brand is Highest Rated in Survey of Ophthalmologists
    9. New Research from Best Practices, LLC Helps Medical Device Companies Earn the Highest Profit Possible During Their Products Patent Lifecycle
    10. Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy
    11. Endovascular Forum and GEST Set Out on a Shared Venture to Bring the Highest Level of Embolization-based Scientific and Technical Education, Results, and Relevance for Patient Care
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/9/2016)... 2016 Research and Markets has announced ... report to their offering. ... The report forecasts the global optical transceiver market to ... The report covers the present scenario and the growth ... the market size, the report considers the revenue generated from the ...
    (Date:12/9/2016)... Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged ... rare diseases, today announced that senior management will participate in a ... at the InterContinental Barclay Hotel in New York City ... About aTyr Pharma ... aTyr Pharma is engaged in the discovery ...
    (Date:12/9/2016)... 2016  Axovant Sciences Ltd. (NYSE: ... on the treatment of dementia, today announced a ... 2b trial evaluating treatment with intepirdine (RVT-101), combined ... plus placebo in people with mild-to-moderate Alzheimer,s disease. ... to treatment was associated with reduced progression in ...
    Breaking Medicine Technology:
    (Date:12/9/2016)... Harrisburg, PA (PRWEB) , ... December 09, 2016 ... ... concussion education program through the Pennsylvania Cable Network (PCN) during the summer of ... Brain Injury Implementation Grant provided by the United States Department of Health and ...
    (Date:12/8/2016)... Pennsylvania (PRWEB) , ... December 08, 2016 , ... ... Duck Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which ... , “This was our first franchise-wide Quack Gives Back initiative, ...
    (Date:12/8/2016)... , ... December 08, 2016 , ... CURE Media Group, ... and advocacy groups, has aligned with Upstage Lung Cancer in efforts to combat lung ... announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored to team up ...
    (Date:12/8/2016)... ... December 08, 2016 , ... SunView Software aims ... employees that are both engaging and easy to use. Coming off the heels ... company revealed today its plans to roll out new AI-powered self-service enhancements to ...
    (Date:12/8/2016)... Dallas, TX (PRWEB) , ... December 08, 2016 , ... ... to continue to be a convenient service for Texas, they are expanding their presence ... will involve a hiring spree that will bring new jobs to the Dallas and ...
    Breaking Medicine News(10 mins):